Literature DB >> 363942

Genetic control of lymphocyte suppression. I. Lack of suppression in aged NZB mice is due to a B cell defect.

D Primi, L Hammarström, C I Smith.   

Abstract

Con A-activated cells from old NZB mice were found capable of inhibiting the polyclonal response of cells from young NZB and BALB/c animals. Furthermore, Con A-preactivated spleen cells from young NZB and BALB/c mice did not significantly affect the response of spleen cells from old NZB mice. These results suggest that the defective suppressive activity in old NZB mice may be traced to a defect at the B cell level.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363942

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  B cell hyperactivity in autoimmune continuous B cell lines.

Authors:  M Aldo-Benson; M S Brooks; L Scheiderer-Pratt
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.

Authors:  P B Nakajima; S K Datta; R S Schwartz; B T Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 3.  Regulatory T cells essential to prevent the loss of self-tolerance in murine models of erythrocyte-specific autoantibody responses.

Authors:  Catherine E Calkins
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

4.  Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

Authors:  J F Delfraissy; P Segond; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

5.  Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.

Authors:  A N Theofilopoulos; D L Shawler; R A Eisenberg; F J Dixon
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

6.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.